[Market Focus] Cha Vaccine Institute Drops Over 15% on CHA Biotech Stake Sale
Cha Vaccine Institute is experiencing a sharp decline in early trading following news of a stake sale by CHA Biotech.
As of 9:15 a.m. on March 19, 2026, shares of Cha Vaccine Institute are trading at 2,650 won, down 495 won (15.74%) from the previous day.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
On this day, Cha Vaccine Institute announced in a regulatory filing that its largest shareholder, CHA Biotech, has signed a share purchase agreement to transfer 8,948,813 shares to Sorux and Aribio Investment Purpose No. 13, among others. The total transaction amount is approximately 23.8 billion won. As a result of this sale, CHA Biotech's ownership stake in Cha Vaccine Institute will decrease to 4.99%.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.